The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Primary Prevention of Cardiovascular Disease in Diabetes Mellitus
Open accessAbstract
Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease (CVD), the most common cause of death in T2D. Yet, <50% of U.S. adults with T2D meet recommended guidelines for CVD prevention. The burden of T2D is increasing: by 2050, approximately 1 in 3 U.S. individuals may have T2D, and patients with T2D will comprise an increasingly large proportion of the CVD population. The authors believe it is imperative that we expand the use of therapies proven to reduce CVD risk in patients with T2D. The authors summarize evidence and guidelines for lifestyle (exercise, nutrition, and weight management) and CVD risk factor (blood pressure, cholesterol and blood lipids, glycemic control, and the use of aspirin) management for the prevention of CVD among patients with T2D. The authors believe appropriate lifestyle and CVD risk factor management has the potential to significantly reduce the burden of CVD among patients with T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Instead, evidence to support lifestyle and health behavior management for T2DM and stable CAD has been extrapolated from primary prevention trials and from subgroups of participants with T2DM from studies focusing on the secondary prevention of CAD.63,136”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [136]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedEstruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1806491 · Cited by 1,008
Retracted(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 4×
“The Look-AHEAD trial, the Steno-2 study, and the DPP all combined different lifestyle parameters, including weight loss, physical activity and exercise, and a dietary intervention (5,7,9).”
BackgroundMethodInfluentialEmpagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2014) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,609
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Cited by
Sorted by citations
Role of the gut microbiota in type 2 diabetes and related diseases
Yang, G., Wei, J., Liu, P., Zhang, Q., Tian, Y., Hou, G., Meng, L., Xin, Y., & Jiang, X. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154712 · Cited by 418
Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy
Marwick, T. H., Ritchie, R., Shaw, J. E., & Kaye, D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.019 · Cited by 365
Arnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Self-citationDiabetes mellitus—Progress and opportunities in the evolving epidemic
Abel, E. D., Gloyn, A. L., Evans‐Molina, C., Joseph, J. J., Misra, S., Pajvani, U. B., Simcox, J., Suszták, K., & Drucker, D. J. (2024) · Cell · doi:10.1016/j.cell.2024.06.029 · Cited by 350
The effects of physical exercise on fatty liver disease.
van der Windt, D. J., Sud, V., Zhang, H., Tsung, A., & Huang, H. (2018) · Gene Expression · doi:10.3727/105221617x15124844266408 · Cited by 294
Cardiovascular Effects of New Oral Glucose-Lowering Agents
Scheen, A. J. (2018) · Circulation Research · doi:10.1161/circresaha.117.311588 · Cited by 292
Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
Poznyak, A. V., Sadykhov, N. K., Kartuesov, A. G., Borisov, E. E., Melnichenko, A. А., Grechko, A. V., & Orekhov, A. N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.959285 · Cited by 229
Qiu, Z., Chen, X., Geng, T., Wan, Z., Lu, Q., Li, L., Zhu, K., Zhang, X., Liu, Y., Lin, X., et al. (2022) · Diabetes Care · doi:10.2337/dc21-2371 · Cited by 202
Fogacci, F., Tocci, G., Presta, V., Fratter, A., Borghi, C., & Cicero, A. F. G. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2017.1422480 · Cited by 144
Wang, G., Wang, Y., Yang, Q., Xu, C., Zheng, Y., Wang, L., Wu, J., Zeng, M., & Luo, M. (2022) · Cell Death and Disease · doi:10.1038/s41419-021-04478-x · Cited by 139
Cardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.046 · Cited by 113
Self-citationBełtowski, J., Wójcicka, G., & Jamróz-Wiśniewska, A. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.004 · Cited by 95
The Changing Landscape of Diabetes Therapy for Cardiovascular Risk Reduction
Newman, J. D., Vani, A. K., Alemán, J. O., WEINTRAUB, H. S., Berger, J. S., & Schwartzbard, A. Z. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.071 · Cited by 95
Self-citationDyslipidemia Management in Adults With Diabetes
Lazarte, J., & Hegele, R. A. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.07.003 · Cited by 88
Cardiovascular Disease in Diabetes and Chronic Kidney Disease
Swamy, S., Noor, S. M., & Mathew, R. O. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12226984 · Cited by 88
Aging and Cardiovascular Disease: Current Status and Challenges
Zhou, M., Zhao, G., Zeng, Y., Zhu, J., Cheng, F., & Liang, W. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2304135 · Cited by 91
Benson, G. A., Sidebottom, A. C., Hayes, J., Miedema, M. D., Boucher, J. L., Vacquier, M. C., Sillah, A., Gamam, S., & VanWormer, J. (2019) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2018.11.013 · Cited by 77
Zhao, S., Feng, X., Huang, T. L., Luo, H., Chen, J., Zeng, J., Gu, M., Li, J., Sun, X., Sun, D., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00212 · Cited by 68
Mechanisms of Abnormal Lipid Metabolism in the Pathogenesis of Disease
Xu, L., Yang, Q., & Zhou, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158465 · Cited by 71
Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events
Yang, Y., Peng, N., Chen, G., Wan, Q., Li, Y., Wang, G., Qin, Y., Luo, Z., Tang, X., Huo, Y., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01447-2 · Cited by 74
Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention
Schwarz, P. E. H., Timpel, P., Harst, L., Greaves, C. J., Ali, M. K., Lambert, J. D., Weber, M. B., Almedawar, M. M., & Morawietz, H. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.07.081 · Cited by 66
Advancements in risk stratification and management strategies in primary cardiovascular prevention
Barkas, F., Şener, Y. Z., Golforoush, P. A., Kheirkhah, A., Rodríguez‐Sánchez, E., Novák, J., Apellániz-Ruiz, M., Akyea, R. K., Bianconi, V., Ceasovschih, A., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.117579 · Cited by 61
Emerging Role of mTOR Signaling‐Related miRNAs in Cardiovascular Diseases
Samidurai, A., Kukreja, R. C., & Das, A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6141902 · Cited by 51
Peng, J., Liu, M., Jin, J., Cao, Y., Guo, Y., Wu, N., Zhu, C., Dong, Q., Sun, J., Xu, R., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01142-0 · Cited by 54
Seidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Mata‐Cases, M., Neijens, A. M. J., Topsever, P., & Khunti, K. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.02.002 · Cited by 60
Chen, J., Lee, S.-Y., Li, Y., Lin, C., Shieh, M., & Ciou, D. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123917 · Cited by 47
Hackett, R. A., Moore, C., Steptoe, A., & Lassale, C. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-35238-1 · Cited by 48
Seidu, S., Cos, X., Brunton, S., Harris, S. B., Jansson, S. P. O., Mata‐Cases, M., Neijens, A. M. J., Topsever, P., & Khunti, K. (2020) · Primary care diabetes · doi:10.1016/j.pcd.2020.05.004 · Cited by 46
Artime, E., Romera, I., Díaz‐Cerezo, S., & Delgado, E. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01060-8 · Cited by 45
Celastrol: A Promising Agent Fighting against Cardiovascular Diseases
Li, Z., Zhang, J., Duan, X., Zhao, G., & Zhang, M. (2022) · Antioxidants · doi:10.3390/antiox11081597 · Cited by 40
Left Ventricular Diastolic Dysfunction in Type 2 Diabetes—Progress and Perspectives
Grigorescu, E.-D., Lăcătușu, C.-M., Floria, M., Mihai, B. M., Crețu, I., & Șorodoc, L. (2019) · Diagnostics · doi:10.3390/diagnostics9030121 · Cited by 39
Wang, W., Li, Z., Zheng, Y., Yan, M., Cui, Y., & Jiang, J. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0964-0 · Cited by 36
Cheng, L., Chen, T., Guo, M., Liu, P., Qiao, X., Wei, Y., She, J., Li, B., Xi, W., Zhou, J., et al. (2021) · Clinical Science · doi:10.1042/cs20210198 · Cited by 36
A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes
Mitchell, S., Malanda, B., Damasceno, A. A. M., Eckel, R. H., Gaiță, D. I., Kotseva, K., Januzzi, J. L., Mensah, G. A., Plutzky, J., Prystupiuk, M., et al. (2019) · Global Heart · doi:10.1016/j.gheart.2019.07.009 · Cited by 35
Ko, M., Kim, Y., Kim, H. H., Jeong, S., Ahn, D., Chung, S. J., & Kim, H. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106041 · Cited by 34
Cao, Y., Liu, H., Sun, D., Jin, J., Xu, R., Guo, Y., Wu, N., Zhu, C., Li, S., Zhang, Y., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.030 · Cited by 31
COSMIC project: consensus on the objectives of the metabolic syndrome in clinic
Pedro‐Botet, J., Ascaso, J. F., Barrios, V., de la Sierra, A., Escalada, J., Millán, J., Mostaza, J. M., Pérez‐Martínez, P., Pintó, X., Salas‐Salvadó, J., et al. (2018) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s165740 · Cited by 31
Branch, M. E., German, C. A., Bertoni, A. G., & Yeboah, J. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2019.04.004 · Cited by 27
Kuo, S. Z., Cepin, S., Bergstrom, J., Siddiqi, H., Jung, J., Lopez, S. J., Huang, D. Q., Taub, P. R., Amangurbanova, M., & Loomba, R. S. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17637 · Cited by 26
Genetic architecture of cardiometabolic risks in people living with HIV
Cheng, H. M., Sewda, A., Márquez‐Luna, C., White, S. R., Whitney, B. M., Williams-Nguyen, J. S., Nance, R. M., Lee, W. J., Kitahata, M. M., Saag, M. S., et al. (2020) · BMC Medicine · doi:10.1186/s12916-020-01762-z · Cited by 26
Wang, B., Li, J., Bao, M., Chen, R., Li, H., Lu, B., Chen, M., Huang, D., Zhang, Y., Gao, F., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8882130 · Cited by 23
Takeuchi, M., Imano, H., Muraki, I., Shimizu, Y., Hayama‐Terada, M., Kitamura, A., Okada, T., Kiyama, M., & Iso, H. (2018) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000492 · Cited by 23
Tang, L. F. P., Wang, H., Dai, B., Wang, X., Zhou, D., Shen, J., Guo, F., Wang, J., Zhou, J., Wang, H., et al. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.03.016 · Cited by 22
Amigó, N., Fuertes-Martín, R., Malo, A. I., Plana, N., Ibarretxe, D., Girona, J., Correig, X., & Masana, L. (2021) · Life · doi:10.3390/life11121407 · Cited by 22
Sun, X., Zhang, C., Ma, Y., He, Y., Zhang, X., & Wu, J. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02201-6 · Cited by 25
Wang, Y., Chen, J., Zheng, Y., Jiang, J., Wang, L., Wu, J., Zhang, C., & Luo, M. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05432-8 · Cited by 21
Towards more specific treatment for diabetic dyslipidemia
Rodriguez, V., Newman, J. D., & Schwartzbard, A. Z. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000528 · Cited by 21
Self-citationOmodanisi, E. I., Tomose, Y., Okeleye, B. I., Ntwampe, S. K. O., & Aboua, Y. G. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17238735 · Cited by 20
Advanced Research of Abdominal Aortic Aneurysms on Metabolism
Hou, Y., Guo, W., Fan, T., Li, B., Ge, W., Gao, R., & Wang, J. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.630269 · Cited by 20
Gaba, P., Bhatt, D. L., Mason, R. P., Miller, M. J., Verma, S., Steg, P. G., & Boden, W. E. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.05.067 · Cited by 22
Hu, T., Zhang, W., Han, F., Zhao, R., Liu, L., & An, Z. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.903412 · Cited by 20
Witkowska, A. M., Waśkiewicz, A., Zujko, M. E., Cicha‐Mikołajczyk, A., Mirończuk-Chodakowska, I., & Drygas, W. (2022) · Nutrients · doi:10.3390/nu14132665 · Cited by 18
Metabolic-associated fatty liver disease and the risk of cardiovascular disease
Zhang, P., Dong, X., Zhang, W., Wang, S., Chen, C., Tang, J., You, Y., Hu, S., Zhang, S., Wang, C., et al. (2022) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2022.102063 · Cited by 18
Racial and Ethnic Disparities in Primary Prevention of Cardiovascular Disease
Ali, M., Nacer, H., Lawson, C. A., & Khunti, K. (2024) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2024.01.028 · Cited by 18
Lordan, R., Τσούπρας, Α., & Zabetakis, I. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813792-5.00002-1 · Cited by 20
King, A., RAJPURA, J. R., Liang, Y. M., Paprocki, Y., & Uzoigwe, C. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2125259 · Cited by 18
Zhang, F., Cao, X., Zhao, C., Chen, L., & Chen, X. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-022-02719-0 · Cited by 16
Barrón‐Cabrera, E., Soria-Rodriguez, R. A., Amador-Lara, F., & Martínez‐López, E. (2023) · Healthcare · doi:10.3390/healthcare11141992 · Cited by 18
Cardio-oncology: Shared Genetic, Metabolic, and Pharmacologic Mechanism
Zhao, Y., Jia, H., Hua, X., An, T., & Song, J. (2023) · Current Cardiology Reports · doi:10.1007/s11886-023-01906-6 · Cited by 19
Yoo, J., Jeon, J., Baek, M., Song, S. O., & Kim, J. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04691-6 · Cited by 17
Yang, Y., Li, Y., Liu, J., Wang, X., Wu, B., He, C.-S., & Gu, J. (2020) · Diabetes and Vascular Disease Research · doi:10.1177/1479164120953626 · Cited by 15
Liu, L., Wu, Q., Yan, H., Chen, B., Zheng, X., & Zhou, Q. (2020) · Disease Markers · doi:10.1155/2020/6659166 · Cited by 15
Huang, X., Yang, S., Zhao, Q., Chen, X., Pan, J., Lai, S., Ouyang, F., Deng, L., Du, Y., Li, X., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.927768 · Cited by 15
Ulambayar, B., Ghanem, A. S., Kovács, N., Trefán, L., Móré, M., & Nagy, A. C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1263365 · Cited by 17
Koh, S. M., Chung, S. H., Yum, Y., Park, S.-J., Joo, H. J., Kim, Y., & Kim, E. J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01681-8 · Cited by 15
Newman, J. D., Berger, J. S., & Ladapo, J. A. (2019) · Diabetes Care · doi:10.2337/dc18-1554 · Cited by 13
Self-citationBucolo, G. M., D’Angelo, T., Yel, İ., Koch, V., Gruenewald, L. D., Othman, A. E., Alizadeh, L. S., Overhoff, D., Waldeck, S. S., Martin, S. S., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13101790 · Cited by 12
Patoulias, D., Stavropoulos, K., Imprialos, K. P., Athyros, V. G., Doumas, M. N., & Karagiannis, A. I. (2019) · Current Vascular Pharmacology · doi:10.2174/1570161117666190426162746 · Cited by 13
Sadraei, S., Aarabi, A., Firouzabadi, S. R., Alinejadfard, M., Mohammadi, I., & Jolfayi, A. G. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-05278-3 · Cited by 13
Li, Y., Lai, Y., Geng, T., Xia, P., Chen, J., Tu, Z., YANG, K. Y., Liao, Y., Liu, G., & Pan, A. (2024) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202300314 · Cited by 13
Salim, M. F., Lubis, I. K., & Sugeng, S. (2019) · Jurnal Manajemen Informasi Kesehatan Indonesia (JMIKI) · doi:10.33560/jmiki.v7i1.216 · Cited by 11
Erkinantti, S., Hautakoski, A., Sund, R., Arffman, M., Urpilainen, E., Puistola, U., Jukkola‐Vuorinen, A., Karihtala, P., & Läärä, E. (2022) · Cancer Control · doi:10.1177/10732748221134090 · Cited by 10
Liu, X., Gong, M., & Wu, N. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1503704 · Cited by 11
Demissie, G. D., Birungi, J., Shrestha, A., Haregu, T., Sathish, T., & Oldenburg, B. F. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104130 · Cited by 14
Hu, Z., Yang, M., Yang, L., Xie, C., Gao, H., Fu, X., Xie, H., & Liu, Y. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/5798764 · Cited by 10
Loyola‐Leyva, A., Loyola-Rodríguez, J. P., Figueroa, Y. T., Camacho-López, S., González, F. J., & Barquera, S. (2020) · Micron · doi:10.1016/j.micron.2020.102982 · Cited by 10
Zhang, X., Lin, S., Zeng, Q., Peng, L., & Yan, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1612369 · Cited by 12
Rana, J. S., Liu, J. Y., Moffet, H. H., Boklage, S., Khan, I., & Karter, A. J. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.05.011 · Cited by 9
Wang, S., Wang, J., Zhang, R., Zhao, A., Zheng, X., Yan, D., Jiang, F., Jia, W. P., Hu, C., & Jia, W. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0808-2 · Cited by 10
Patoulias, D., Papadopoulos, C. E., Zografou, I., Katsimardou, A., Karagiannis, A. I., & Doumas, M. N. (2022) · Medicina · doi:10.3390/medicina58091167 · Cited by 9
Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach
Dugani, S. B., Ames, J. M., Manson, J. E., & Mora, S. (2018) · Current Atherosclerosis Reports · doi:10.1007/s11883-018-0717-y · Cited by 8
Cao, D., Wang, Y., Li, W., Ji, J.-F., Guo, J., Zhang, D., & Liu, J. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12715 · Cited by 7
Yao, H., Li, L., Wang, X., & Wang, Z. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01417-6 · Cited by 7
Hu, C., Tkebuchava, T., & Wu, Q. (2024) · Cardiovascular Science · doi:10.35534/cvs.2024.10004 · Cited by 10
THE IMPACT OF THE DIABETES ON ORAL HEALTH – AN OBSERVATIONAL STUDY
Çanga, M., Malagnino, I., Qafmolla, A., Xhajanka, E., & Malagnino, V. A. (2022) · Wiadomości Lekarskie · doi:10.36740/wlek202204101 · Cited by 7
KONES, R. J., & Rumana, U. (2018) · Postgraduate Medicine · doi:10.1080/00325481.2018.1421395 · Cited by 7
The effect of deprivation on coronary heart disease mortality rate
Theocharidou, L., & Mulvey, M. R. (2018) · Bioscience Horizons The International Journal of Student Research · doi:10.1093/biohorizons/hzy007 · Cited by 7
Hou, W., Yin, S., Li, P., Zhang, L., Chen, T., Qin, D., Mustafa, A. U., Liu, C., Song, M., Qiu, C., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05198-z · Cited by 6
Patoulias, D., & Dimosiari, A. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2022.05.005 · Cited by 6
Chaudhary, R. S., Turner, M. B., Mehta, L. S., Al-Roub, N., Smith, S. C., & Kazi, D. S. (2023) · Diabetes Care · doi:10.2337/dc23-1731 · Cited by 6
García–Moll, X., Barrios, V., & Franch‐Nadal, J. (2021) · Drugs in Context · doi:10.7573/dic.2021-6-3 · Cited by 6
Wang, S., Zhang, R., Wang, T., Jiang, F., Hu, C., & Jia, W. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.10.006 · Cited by 6
Diabetes mellitus is associated with high sleep-time systolic blood pressure and non-dipping pattern
Aung, A. T., Chan, S. P., Kyaing, T.-T., & Lee, C. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1745537 · Cited by 7
Machado‐Duque, M. E., García-Ospina, D. A., Emura-Vélez, M. H., Gaviria‐Mendoza, A., & Machado‐Alba, J. E. (2021) · Journal of Primary Care & Community Health · doi:10.1177/21501327211007015 · Cited by 5
Williams, B. A., Brady, J. P., Voyce, S. J., Kumar, N., Paprocki, Y., & RAJPURA, J. R. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14686 · Cited by 5
Dika, H., Deogratias, M., Byamungu, D., Marwa, K. J., Kapesa, A., & Mwita, S. M. (2023) · East African Health Research Journal · doi:10.24248/eahrj.v7i1.712 · Cited by 5
Pontoppidan, J. R. N., Nielsen, E. E., Olsen, M. H., Skjødt, M. K., Christensen, J. O., Raymond, I. E., Møller, S. H., Soja, A. M. B., & Gæde, P. (2024) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2024.102594 · Cited by 7
A network analysis framework of genetic and nongenetic risks for type 2 diabetes
Zhang, Y., Li, S., Cao, Z., Cheng, Y., Xu, C., Yang, H., Sun, L., Jiao, H., Ju, W., Li, W., et al. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09585-2 · Cited by 4
Factors associated with work ability in adults with diabetes
McCarthy, M. M., Yan, J., & Dickson, V. V. (2021) · Applied Nursing Research · doi:10.1016/j.apnr.2021.151478 · Cited by 5
Zhou, W., Yu, Y., Zhu, L., Fang, W., Yu, T., Li, M., Huang, X. B., Wang, T., Bao, H., & Cheng, X. (2021) · International Journal of Endocrinology · doi:10.1155/2021/7722269 · Cited by 5
Metadata
- Authors
- Newman, J. D., Schwartzbard, A. Z., Weintraub, H. S., Goldberg, I. J., & Berger, J. S.
- Affiliations
- NYU Langone Health (US)
- Corresponding author
- Newman, Jonathan D.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 70
- Issue
- 7
- Pages
- 883-893
- ISSN
- 0735-1097 (ISSN-L)
- PMC
- PMC5656394
- OpenAlex
- W2744536672
- Cited by
- 205
- References
- 89
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 28 · 2023: 22 · 2022: 57 · 2021: 18 · 2020: 21 · 2019: 14 · 2018: 20 · 2017: 2
- FWCI
- 2.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- American Heart Association (15MCPRP24480132)
- Amgen
- AstraZeneca
- Sanofi
- Gilead Sciences
- Amarin Corporation
- National Institutes of Health (HL114978)
- National Heart, Lung, and Blood Institute (P01HL092969, K23HL125991, HL-114978, R01HL114978)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- type 2 diabetes, cardiovascular disease prevention, primary prevention, lifestyle modification, physical activity, nutrition, weight management, blood pressure control, glycemic control, aspirin therapy, cardiovascular risk factors
- MeSH terms
- Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Morbidity, Primary Prevention, Risk Factors, Global Health
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
